// App-Quantinova.ai

758 : Minimal Residual Disease Assessment of Remission after Induction Therapy Is Superior to Morphologic Assessment for Risk Stratification in Childhood Acute Lymphoblastic Leukemia: A Report from the Children's Oncology Group (COG)

Researchers

Presenter

  • Sumit Gupta

Principal Investigators

  • Si Chen

  • Eric Larsen

  • Kelly Maloney

  • Leonard A. Mattano Jr

  • Stuart Winter

  • Naomi Winick

  • William L. Carroll

  • Stephen P. Hunger

  • Michael J. Borowitz

  • Brent L. Wood

  • Cindy Wang

  • Mignon L. Loh

  • Elizabeth Raetz

  • Patrick Brown

  • Andrew J. Carroll

  • Nyla A. Heerema

  • Julie M. Gastier-Foster

  • Kimberly P. Dunsmore

Medical Centers

  • Department of Biostatistics, University of Florida, Gainesville, FL

  • Dept. of Pediatrics and the Hellen Diller Family Comprehensive Cancer Center, Benioff Children's Hospital, University of California at San Francisco, San Francisco, CA

  • Hematologic Pathology, Johns Hopkins University, Baltimore, MD

  • Pediatric Oncology, The Johns Hopkins University School of Medicine, Baltimore, MD

  • Hunstman Cancer Institute of Utah, Salt Lake City, UT

  • Division of Hematology, Department of Internal Medicine, The Ohio State University Comprehensive Cancer Center, Columbus, OH

  • Internal Medicine, University of Virginia, Charlottesville, VA

  • Dept of Biostatistics, Colleges of Medicine, Public Health & Health Professions, University of Florida, Gainsville, FL

  • HARP Pharma Consulting, LLC, Mystic, CT

  • Dept of Biostatistics, Colleges of Medicine, Public Health & Health Professions, University of Florida, Gainsville, FL

  • Division of Haematology Oncology, The Hospital for Sick Children, University of Toronto, Toronto, ON, Canada

  • Children's Hospital Colorado, Aurora, CO

  • Division of Pediatric Hematology Oncology, Department of Pediatrics, Perlmutter Cancer Center, New York University Langone Medical Center, New York, NY

  • Department of Pathology and Laboratory Medicine,, Nationwide Children's Hospital, Columbus, OH

  • Seattle Cancer Care Alliance, Seattle, WA

  • Children's Hospital of Philadelphia and the Center for Childhood Cancer Research, Philadelphia, PA

  • Department of Surgery, University of Toronto, Toronto, ON, Canada

  • Pediatrics (Hem/Onc and ID) and Microbiology, University of Texas Southwestern Medical Center, Dallas, TX

  • University of New Mexico Cancer Center, Albuquerque, NM

  • Maine Childrens Cancer Program, Scarborough, ME

  • Department of Radiation Oncology, University of Alabama at Birmingham, Birmingham, AL

Locations

  • United States

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Acute lymphoblastic leukemia

  • B-cell acute lymphoblastic leukemia

  • T-cell acute lymphoblastic leukemia

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved